XANTHINES INHIBIT HUMAN PLATELET AGGREGATION INDUCED BY PLATELET‐ACTIVATING FACTOR

Authors:

Abstract
SUMMARY: 1. Platelet‐activating factor (PAF) may be involved in the pathogenesis of asthma, and therefore the effects of the anti‐asthma drugs theophylline and enprofylline on human platelet aggregation and adenosine triphosphate (ATP) release induced by PAF and adenosine diphosphate (ADP) were studied.2. Enprofylline (50% inhibitory concentration [IC50] = 94.8±13.2 μmol/L) was more potent than theophylline (IC50= 934.1±40.1 μmol/L) as an inhibitor of PAF‐induced aggregation, and the xanthines were twice as potent as inhibitors of PAF‐induced aggregation when compared with ADP‐induced aggregation. ATP release was 1.4 times more sensitive to inhibition by the xanthines than aggregation.3. Although high concentrations of xanthines inhibited platelet aggregation and ATP release induced by PAF, therapeutic concentrations are unlikely to inhibit PAF‐induced effects.

This publication has 16 references indexed in Scilit: